Hyaluronidase Market by Types (Animal-derived, and Synthetic), Applications (Dermatology, Chemotherapy, Ophthalmology, Plastic Surgery, and Others), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028
The global hyaluronidase market size is anticipated to expand at a substantial CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the increasing penetration through different applications and incidence of multiple case studies to demonstrate product efficiency.
Applications of hyaluronidase are ophthalmic therapeutic solutions, cosmetic treatments, and cancer therapy. Its developing role in cancer metastasis and therapy due to enzyme based substrates used for noninvasive tumor imaging is projected to propel the demand and subsequent growth of the market with lucrative avenues. The demand of cosmetics and aesthetics procedures is rising with increasing awareness about alteration of physical appearance among people. Due to easy access of advanced cosmetic treatments and growing prevalence of skin disorders the demand of hyaluronidase is rising across cosmetic dermatology.
Hyaluronidase therapy supports in dissolving subcutaneous nodules and correct excessive injected fillers. Due to this interest of professionals has increased in cosmetic industry for gaining knowledge about its adverse effects, use, and applications. In the hyaluronic acid fillers management adoption of enzyme has increased because of all these factors. Though, there are some symptoms of overdose which are sweating, vision, and confusion among others.
Hence, the beautician or practitioner should be skilled and knowledgeable with appropriate dosage of hyaluronidase including information about required remedies and possible complications. Growing advancements focuses on reducing side effects of hyaluronidase administration are anticipated to offer beneficial opportunities to the major market players.
Market Trends, Drivers, Restraints, and Opportunities
- Growing prevalence of cancer, technological advancements, and various applications in cancer therapy are projected to fuel the market expansion over the forecast period.
- Easy accessibility and availability of medicines made out of hyaluronidase and ophthalmic therapeutic solutions are anticipated to drive the growth of the market.
- Globally, rising awareness among people about physical appearance is expected to push the market growth in the coming years.
- Growing number of people opting for aesthetic nonsurgical procedures, rising geriatric population, and favorable reimbursement policies are anticipated to boost the market growth.
- Several side effects of the product such as dizziness, rapid heartbeats, unusual weakness, and skin rashes are projected to impede the market growth over the forecast period.
Scope of the Report
The report on the global hyaluronidase market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
| Attributes | Details |
| Report Title | Hyaluronidase Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
| Base Year | 2020 |
| Historic Data | 2018–2019 |
| Forecast Period | 2021–2028 |
| Segmentation | Types (Animal-derived, and Synthetic), Applications (Dermatology, Chemotherapy, Ophthalmology, Plastic Surgery, and Others) |
| Regional Scope | Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
| Report Coverage | Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
| Key Players Covered in the Report | Amphastar Pharmaceuticals, Inc., PrimaPharma, Inc., Halozyme, Inc., Bausch & Lomb Incorporated, The Cooper Companies Inc., Sun Pharmaceutical Industries Ltd., STEMCELL Technologies Inc., and Shreya Life Sciences Pvt. Ltd. |
Market Segment Insights
Animal-derived segment is projected to hold a key market share
In terms of types, the hyaluronidase market is segmented into animal-derived and synthetic. The animal-derived segment is expected to hold a key share of the market in the coming years. Various commercial and approved brand are present in the market which are derived from animal sources. Though, due to limitations related to animal-derived products have encouraged the development and usage of synthetic products. The safety and quality of local anesthetic blocks has enhanced by the high efficacy of recombinant human hyaluronidase.
To make sure the correct selection of products, professional must aware about different properties of sources. While recommending therapy Practitioners must analyze the products from confirmed source to make informed decisions. The most widely used animal sources are bovine and porcine products where, synthetic products includes human recombinant sources.
Chemotherapy segment is expected to grow at a rapid pace
On the basis of applications, the hyaluronidase market is divided into chemotherapy, ophthalmology, plastic surgery, and others. Usage of hyaluronidase is increased majorly in medicine, to augment dispersion and absorption of other injected drugs. Hence, use of hyaluronidase is increased in chemotherapy & osteoarthritis which boosts the generation of revenue. Hence, chemotherapy segment is expected to grow at rapid space over the forecast period.
The growing incidences of hyaluronidase use in dermatology results in largest revenue generation. Establishing a standard protocol is projected to drive the market growth in coming years. Injections are employed in chemotherapy indications. Many case studies and research recommended its use to resolve extravasation. Utility as a complement in chemotherapy is related with improved tumor response to chemotherapeutic drugs.
Asia Pacific is expected to dominate the market
On the basis of regions, the hyaluronidase market is categorized as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. The market of North America is anticipated to expand at an impressive CAGR during the forecast period. The regional market growth can be attributed to occurrence of large number of dermatology clinics prescribing such treatments, presence of major players who manufactures these products, and high acceptance of advanced treatment.
However, the market of Asia Pacific is expected to exhibit a rapid growth rate in the coming years due to importance of medical tourism for dermatology treatments and chemotherapy applications in several countries. This has encouraged numerous international companies for interments in Asia Pacific. Prevalence of large number of suppliers along with advanced technology in South Korea is driving the growth of the Asian market.
Segments
Segments Covered in the ReportThe global hyaluronidase market has been segmented on the basis of
Types
- Animal-derived Hyaluronidase
- Synthetic Hyaluronidase
- Dermatology
- Chemotherapy
- Ophthalmology
- Plastic Surgery
- Others
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
- Amphastar Pharmaceuticals, Inc.
- PrimaPharma, Inc.
- Halozyme, Inc.
- Bausch & Lomb Incorporated
- The Cooper Companies Inc.
- Sun Pharmaceutical Industries Ltd.
- STEMCELL Technologies Inc.
- Shreya Life Sciences Pvt. Ltd.
Competitive Landscape
Key players competing in the hyaluronidase market include Amphastar Pharmaceuticals, Inc., PrimaPharma, Inc., Halozyme, Inc., Bausch & Lomb Incorporated, The Cooper Companies Inc., Sun Pharmaceutical Industries Ltd., STEMCELL Technologies Inc., and Shreya Life Sciences Pvt. Ltd.
Major market players implement various business strategies such as mergers, acquisitions, partnerships, collaborations, capacity expansion, and product launches to enhance their market shares. For instance, Genetech, Inc., a subsidiary of Roche Holding AG, in February 2019, received FDA approval for its product-Herceptin Hylecta. Herceptin Hylecta is a subcutaneous injection used for treatment of breast cancer patients.
2. Assumptions and Acronyms Used
3. Research Methodology
4. Hyaluronidase Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Hyaluronidase Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Hyaluronidase Market - Supply Chain
4.5. Global Hyaluronidase Market Forecast
4.5.1. Hyaluronidase Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Hyaluronidase Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Hyaluronidase Market Absolute $ Opportunity
5. Global Hyaluronidase Market Analysis and Forecast by Types
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Types
5.2.2. Y-o-Y Growth Projections by Types
5.3. Hyaluronidase Market Size and Volume Forecast by Types
5.3.1. Animal-derived Hyaluronidase
5.3.2. Synthetic Hyaluronidase
5.4. Absolute $ Opportunity Assessment by Types
5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global Hyaluronidase Market Analysis and Forecast by Region
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Region
6.2.2. Y-o-Y Growth Projections by Region
6.3. Hyaluronidase Market Size and Volume Forecast by Region
6.3.1. North America
6.3.2. Latin America
6.3.3. Europe
6.3.4. Asia Pacific
6.3.5. Middle East and Africa (MEA)
6.4. Absolute $ Opportunity Assessment by Region
6.5. Market Attractiveness/Growth Potential Analysis by Region
6.6. Global Hyaluronidase Demand Share Forecast, 2019-2026
7. North America Hyaluronidase Market Analysis and Forecast
7.1. Introduction
7.1.1. Basis Point Share (BPS) Analysis by Country
7.1.2. Y-o-Y Growth Projections by Country
7.2. North America Hyaluronidase Market Size and Volume Forecast by Country
7.2.1. U.S.
7.2.2. Canada
7.3. Absolute $ Opportunity Assessment by Country
7.4. North America Hyaluronidase Market Size and Volume Forecast by Types
7.4.1. Animal-derived Hyaluronidase
7.4.2. Synthetic Hyaluronidase
7.5. Basis Point Share (BPS) Analysis by Types
7.6. Y-o-Y Growth Projections by Types
7.7. Market Attractiveness/Growth Potential Analysis
7.7.1. By Country
7.7.2. By Product Type
7.7.3. By Application
7.8. North America Hyaluronidase Demand Share Forecast, 2019-2026
8. Latin America Hyaluronidase Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.1.3. Latin America Average Pricing Analysis
8.2. Latin America Hyaluronidase Market Size and Volume Forecast by Country
8.2.1. Brazil
8.2.2. Mexico
8.2.3. Rest of Latin America
8.3. Absolute $ Opportunity Assessment by Country
8.4. Latin America Hyaluronidase Market Size and Volume Forecast by Types
8.4.1. Animal-derived Hyaluronidase
8.4.2. Synthetic Hyaluronidase
8.5. Basis Point Share (BPS) Analysis by Types
8.6. Y-o-Y Growth Projections by Types
8.7. Market Attractiveness/Growth Potential Analysis
8.7.1. By Country
8.7.2. By Product Type
8.7.3. By Application
8.8. Latin America Hyaluronidase Demand Share Forecast, 2019-2026
9. Europe Hyaluronidase Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Europe Average Pricing Analysis
9.2. Europe Hyaluronidase Market Size and Volume Forecast by Country
9.2.1. Germany
9.2.2. France
9.2.3. Italy
9.2.4. U.K.
9.2.5. Spain
9.2.6. Russia
9.2.7. Rest of Europe
9.3. Absolute $ Opportunity Assessment by Country
9.4. Europe Hyaluronidase Market Size and Volume Forecast by Types
9.4.1. Animal-derived Hyaluronidase
9.4.2. Synthetic Hyaluronidase
9.5. Basis Point Share (BPS) Analysis by Types
9.6. Y-o-Y Growth Projections by Types
9.7. Market Attractiveness/Growth Potential Analysis
9.7.1. By Country
9.7.2. By Product Type
9.7.3. By Application
9.8. Europe Hyaluronidase Demand Share Forecast, 2019-2026
10. Asia Pacific Hyaluronidase Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Asia Pacific Average Pricing Analysis
10.2. Asia Pacific Hyaluronidase Market Size and Volume Forecast by Country
10.2.1. China
10.2.2. Japan
10.2.3. South Korea
10.2.4. India
10.2.5. Australia
10.2.6. Rest of Asia Pacific (APAC)
10.3. Absolute $ Opportunity Assessment by Country
10.4. Asia Pacific Hyaluronidase Market Size and Volume Forecast by Types
10.4.1. Animal-derived Hyaluronidase
10.4.2. Synthetic Hyaluronidase
10.5. Basis Point Share (BPS) Analysis by Types
10.6. Y-o-Y Growth Projections by Types
10.7. Market Attractiveness/Growth Potential Analysis
10.7.1. By Country
10.7.2. By Product Type
10.7.3. By Application
10.8. Asia Pacific Hyaluronidase Demand Share Forecast, 2019-2026
11. Middle East & Africa Hyaluronidase Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Middle East & Africa Average Pricing Analysis
11.2. Middle East & Africa Hyaluronidase Market Size and Volume Forecast by Country
11.2.1. Saudi Arabia
11.2.2. South Africa
11.2.3. UAE
11.2.4. Rest of Middle East & Africa (MEA)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Middle East & Africa Hyaluronidase Market Size and Volume Forecast by Types
11.4.1. Animal-derived Hyaluronidase
11.4.2. Synthetic Hyaluronidase
11.5. Basis Point Share (BPS) Analysis by Types
11.6. Y-o-Y Growth Projections by Types
11.7. Market Attractiveness/Growth Potential Analysis
11.7.1. By Country
11.7.2. By Product Type
11.7.3. By Application
11.8. Middle East & Africa Hyaluronidase Demand Share Forecast, 2019-2026
12. Competition Landscape
12.1. Global Hyaluronidase Market: Market Share Analysis
12.2. Hyaluronidase Distributors and Customers
12.3. Hyaluronidase Market: Competitive Dashboard
12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
12.4.1. Amphastar Pharmaceuticals, Inc.
12.4.2. PrimaPharma, Inc.
12.4.3. Halozyme, Inc.
12.4.4. Bausch & Lomb Incorporated
12.4.5. The Cooper Companies Inc.
12.4.6. Sun Pharmaceutical Industries Ltd.
12.4.7. STEMCELL Technologies Inc.
The global hyaluronidase market has been segmented on the basis of
Types
- Animal-derived Hyaluronidase
- Synthetic Hyaluronidase
- Dermatology
- Chemotherapy
- Ophthalmology
- Plastic Surgery
- Others
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
- Amphastar Pharmaceuticals, Inc.
- PrimaPharma, Inc.
- Halozyme, Inc.
- Bausch & Lomb Incorporated
- The Cooper Companies Inc.
- Sun Pharmaceutical Industries Ltd.
- STEMCELL Technologies Inc.
- Shreya Life Sciences Pvt. Ltd.
Key players competing in the hyaluronidase market include Amphastar Pharmaceuticals, Inc., PrimaPharma, Inc., Halozyme, Inc., Bausch & Lomb Incorporated, The Cooper Companies Inc., Sun Pharmaceutical Industries Ltd., STEMCELL Technologies Inc., and Shreya Life Sciences Pvt. Ltd.
Major market players implement various business strategies such as mergers, acquisitions, partnerships, collaborations, capacity expansion, and product launches to enhance their market shares. For instance, Genetech, Inc., a subsidiary of Roche Holding AG, in February 2019, received FDA approval for its product-Herceptin Hylecta. Herceptin Hylecta is a subcutaneous injection used for treatment of breast cancer patients.
Our Clients
Related Reports
Some other reports from this category!
